Module I NCM 118
Module I NCM 118
Nursing
Introduction
Nurses constitute the largest category of healthcare personnel in nearly every country of the global
community. They are the key professionals who need to be included in the process of setting a worldwide
agenda for holistic patient care.
As you begin the study of critical care nursing, you may be excited, uncertain, and even somewhat anxious.
The field of critical care nursing often seems a little unfamiliar or mysterious, making it hard to imagine
what the experience will be like or what nurses do in this area.
This module presents essential information about how to safely and competently care for critically ill
patients and their families.
Procedure
1. Once an arterial site is selected (radial, brachial, femoral, or dorsalis pedis), collateral circulation to the
area must be confirmed before the catheter is placed. This is a safety precaution to prevent compromised
arterial perfusion to the area distal to the arterial catheter insertion site. If no collateral circulation exists and
the cannulated artery became occluded, ischemia and infarction of the area distal to that artery could occur.
2. Collateral circulation to the hand can be checked by the Allen test
3. With the Allen test, the nurse compresses the radial and ulnar arteries simultaneously and asks the patient
to make a fist, causing the hand to blanch.
4. After the patient opens the fist, the nurse releases the pressure on the ulnar artery while maintaining
pressure on the radial artery. The patient’s hand will turn pink if the ulnar artery is patent.
Complications
• Local destruction with distal ischemia
• external hemorrhage
• massive ecchymosis
• dissection
• air embolism
• blood loss
• pain
• arteriospasm
• infection
Nursing Interventions
1. Before insertion of a catheter, the site is prepared by shaving if necessary and by cleansing with an
antiseptic solution. A local anesthetic may be used.
2. Once the arterial catheter is inserted, it is secured and a dry, sterile dressing is applied.
3. The site is inspected daily for signs of infection. The dressing and pressure monitoring system or water
manometer are changed according to hospital policy.
4. In general, the dressing is to be kept dry and air occlusive.
5. Dressing changes are performed with the use of sterile technique.
6. Arterial catheters can be used for infusing intravenous fluids, administering intravenous medications, and
drawing blood specimens in addition to monitoring pressure.
7. To measure the arterial pressure, the transducer (when a pressure monitoring system is used) or the zero
mark on the manometer (when a water manometer is used) must be placed at a standard reference point,
called the phlebostatic axis.
8. After locating this position, the nurse may make an ink mark on the chest.
2.CENTRAL VENOUS PRESSURE
• The CVP, the pressure in the vena cava or right atrium, is used to assess right ventricular function and
venous blood return to the right side of the heart. The CVP can be continuously measured by connecting
either a catheter positioned in the vena cava or the proximal port of a pulmonary artery catheter to a pressure
monitoring system
Procedure
1. Before insertion of a CVP catheter, the site is prepared by shaving if necessary and by cleansing with an
antiseptic solution.
2. A local anesthetic may be used. The physician threads a single lumen or multilumen catheter through the
external jugular, antecubital, or femoral vein into the vena cava just above or within the right atrium
Nursing Interventions
1. Once the CVP catheter is inserted, it is secured and a dry, sterile dressing is applied.
2. Catheter placement is confirmed by a chest x-ray, and the site is inspected daily for signs of infection. The
dressing and pressure monitoring system or water manometer are changed according to hospital policy.
3. In general, the dressing is to be kept dry and air occlusive.
4. Dressing changes are performed with the use of sterile technique.
5. CVP catheters can be used for infusing intravenous fluids, administering intravenous medications, and
drawing blood specimens in addition to monitoring pressure.
6. To measure the CVP, the transducer (when a pressure monitoring system is used) or the zero mark on the
manometer (when a water manometer is used) must be placed at a standard reference point, called the
phlebostatic axis.
7. After locating this position, the nurse may make an ink mark on the chest.
Summary:
Hemodynamic monitoring is the assessment of the patient’s circulatory status; it includes measurements of
heart rate (HR), intra-arterial pressure, CO, central venous pressure (CVP), PAP, pulmonary artery wedge
pressure and blood volume.
The primary purpose is the early detection, identification, and treatment of life-threatening conditions, such
as heart failure, cardiac tamponade, and all types of shock (septic, cardiogenic, neurogenic, anaphylactic).
Cardiac Output
CO is the amount (volume) of blood ejected by the left ventricle into the aorta in 1 minute. Normal CO is 4
to 8 L/minute.
Underlying Concepts
1. CO is determined by stroke volume (SV) and HR. Thus, CO = SV x HR. CO must be maintained to
adequately oxygenate the body.
a. HR = number of cardiac contractions per minute.
b. SV = amount of blood ejected from ventricle per beat (normal SV is 50 to 100ml/beat). The amount of
blood returning to the heart (preload), venous tone, resistance imposed on the ventricle before ejection
(afterload), and the integrity of the cardiac muscle (contractility) influence the functioning of this
determinant.
2. The body alters CO through increases or decreases in one or both of these parameters. CO is maintained if
the HR falls by an increase in SV. Likewise, a decrease in SV produces a compensatory rise in HR to keep
the CO normal.
3. CO will decrease if either of the determinants cannot inversely compensate for the other.
4. CO measurements are adjusted to patient size by calculating the cardiac index (CI). CI equals CO divided
by body surface area (BSA); BSA is determined through standard charts based on individual height and
weight. Normal CI is 2.5 to 4 L/minute/m2.
Central Venous Pressure Monitoring
1. Refers to the measurement of right atrial pressure or the pressure of the great veins within the thorax
(normal range: 5 to10 cm H2O or 2 to 8 mm Hg).
a. Right-sided cardiac function is assessed through the evaluation of CVP.
b. Left-sided heart function is less accurately reflected by the evaluation of CVP but may be useful in
assessing chronic right- and left-sided heart failure and differentiating right and left ventricular infarctions.
2. Requires the threading of a catheter into a large central vein (subclavian, internal or external jugular,
median basilic, or femoral). The catheter tip is then positioned in the right atrium, upper portion of the
superior vena cava, or the inferior vena cava (femoral approach only).
3. Purposes of CVP catheter and monitoring include:
a. To serve as a guide for fluid replacement.
b. To monitor pressures in the right atrium and central veins.
c. To administer blood products, total parenteral nutrition, and drug therapy contraindicated for peripheral
infusion.
d. To obtain venous access when peripheral vein sites are inadequate.
e. To obtain central venous blood samples.
Purposes of Pulmonary Artery Pressure Monitoring:
1. To monitor pressures in the right atrium (CVP), right ventricle, pulmonary artery, and distal branches of
the pulmonary artery (pulmonary capillary wedge pressure [PCWP]). The latter reflects the level of the
pressure in the left atrium (or filling pressure in the left ventricle); thus, pressures on the left side of the heart
are inferred from pressure measurement obtained on the right side of the circulation.
2. To obtain blood for central venous oxygen saturation.
2. The balloon catheter is attached to an external console, allowing for inflation and deflation of the balloon
with gas such as CO2.
3. The external console integrates the inflation and deflation sequence with the mechanical events of the
cardiac cycle (systole-diastole) by “triggering” gas delivery in synchronization with the patient’s ECG, the
patient’s arterial waveform, or an intrinsic pump rate.
a. The most common method of “triggering” the IABP is from the R wave of the patient’s ECG signal
(IABP catheter will deflate on the R wave).
b. The balloon is automatically set to inflate in the middle of the T wave or at the dicrotic notch of the
arterial waveform.
4. Eases the workload of a damaged heart by increasing coronary blood flow (diastolic augmentation) and
decreasing the resistance in the arterial tree against which the heart must pump (afterload reduction).
5. This results in an increase in CO and a reduction in myocardial oxygen requirements.
6. The balloon is inflated at the onset of diastole; this results in an increase in diastolic aortic pressure
(diastolic augmentation), which increases blood flow through the coronary arteries.
7. The balloon is deflated just before the onset of systole, facilitating the emptying of blood from the left
ventricle and decreasing pressure within the aorta. This action results in less work for the left ventricle.
Contraindications
1. Aortic aneurysm—IABP catheter may perforate a weakened vessel wall leading to thrombus formation,
and inflation and deflation of the catheter may cause a thrombus to break off to become an embolus.
2. Peripheral vascular disease—femoral or iliac artery insertion may be impossible in a patient with severe
vascular disease.
3. Terminal illness—outcome will not be affected, unless the patient meets the criteria for heart
transplantation.
4. Coagulopathy—increases the risk of bleeding.
Complications
1. Vascular injuries that may occur from IABP are:
a. Plaque dislodging
b. Laceration of the aorta
c. Ischemia of the limb distal to the insertion site
d. Arterial perforation.
2. Peripheral nerve damage can occur from IABP if a cutdown was used to insert the catheter.
3. Impairment of cerebral circulation due to balloon migration occluding the subclavian artery or by embolus
and impairment of renal circulation due to balloon malposition or embolus. (Impaired circulation occurs
more frequently in patients with peripheral vascular occlusive disease, in women with small vessels, and in
patients with insulin-dependent diabetes.)
4. Infection at the insertion site and septicemia occurs in 0.2% of patients with IABP.
5. Thrombocytopenia.
6. Hemorrhage due to anticoagulation.
Nursing Diagnosis
• Anxiety related to invasive procedure, critical illness, and environment
• Decreased Cardiac Output related to myocardial ischemia and/or mechanical intervention
• Impaired Tissue Perfusion related to foreign body in aorta
Nursing Interventions:
Relieving Anxiety
1. Explain IABP therapy to patient and family geared to their level of understanding.
a. Review purpose of therapy and how the IABP functions.
b. Reinforce mobility restrictions: supine position with head of bed elevated 15 to 30 degrees, no movement
or flexing of leg with IABP catheter.
c. Explain need for frequent monitoring of vital signs, rhythm, affected extremity, and pulses.
d. Discuss the sounds associated with functioning external console: balloon inflation and deflation and
alarms.
2. Encourage family members to participate in patient’s care.
a. Allow family to visit patient frequently.
b. Solicit family members’ assistance in reinforcing mobility restrictions to patient and notifying nursing
staff of patient comfort needs.
c. Encourage family members to ask questions.
3. Allow patient to verbalize fears regarding therapy and illness.
4. Make sure that informed consent is obtained.
5. Administer anxiolytic medications as prescribed and indicated.
6. Keep the family informed of changes in the patient’s condition.
7. Encourage realistic hope based on the patient’s condition and discuss the patient’s progress with the
family.
8. Determine the family’s previous coping mechanism to stressful situations.
5. Endotracheal tube
A flexible tube inserted through the mouth or nose and into the trachea beyond the vocal cords that acts as
an artificial airway
a. Maintains a patent airway.
b. Allows for deep tracheal suction and removal of secretions.
c. Permits mechanical ventilation.
d. Inflated balloon seals off trachea so aspiration from the GI tract cannot occur.
e. Generally easy to insert in an emergency, but maintaining placement is more difficult so this is not for
long-term use.
6. Tracheostomy tube
A firm curved artificial airway inserted directly into the trachea at the level of the second or third tracheal
ring through a surgically made incision.
a. Permits mechanical ventilation and facilitates secretion removal.
b. Can be for long-term use.
c. Bypasses upper airway defenses, increasing susceptibility to infection.
d. Allows the patient to eat and swallow.
Types of Ventilators
Negative Pressure Ventilators
1. Applies negative pressure around the chest wall. This causes intra-airway pressure to become negative,
thus drawing air into the lungs through the patient’s nose and mouth.
2. No artificial airway is necessary; patient must be able to control and protect own airway.
3. Indicated for selected patients with respiratory neuromuscular problems, or as adjunct to weaning from
positive pressure ventilation.
4. Examples are the iron lung and cuirass (shell unit) ventilator.
Positive Pressure Ventilators
During mechanical inspiration, air is actively delivered to the patient’s lungs under positive pressure.
Exhalation is passive. Requires use of a cuffed artificial airway.
Pressure cycled.
a. Delivers selected gas pressure during inspiratory phase.
b. Volume delivered depends on lung compliance and resistance.
Modes of Operation
Controlled Ventilation
1. Patient receives a set number and volume of breaths/ minute.
2. Provides a fixed level of ventilation, but will not cycle or have gas available in circuitry to respond to
patient’s own inspiratory efforts. This typically increases work of breathing for patients attempting to
breathe spontaneously.
3. Generally used for patients who are unable to initiate spontaneous breaths.
Assist/Control
1. Inspiratory cycle of ventilator is activated by the patient’s voluntary inspiratory effort and delivers a
preset full volume.
2. Ventilator also cycles at a rate predetermined by the operator.
3. Indicated for patients who are breathing spontaneously, but who have the potential to lose their respiratory
drive or muscular control of ventilation. In this mode, the patient’s work of breathing is greatly reduced.
Intermittent Mandatory Ventilation (IMV)
1. Allows patients to breathe at their own rate and volume spontaneously through ventilator circuitry.
2. Periodically, at preselected rate and volume or pressure, cycles to give a “mandated” ventilator breath.
3. Ensures that a predetermined number of breaths at a selected tidal volume are delivered each minute.
4. Gas provided for spontaneous breaths usually flows continuously through the ventilator.
5. Indicated for patients who are breathing spontaneously, but at a VT and/or rate less than adequate for their
needs. Allows the patient to do some of the work of breathing.
Synchronized Intermittent Mandatory Ventilation (SIMV)
1. Allows patient to breathe at their own rate and volume spontaneously through the ventilator circuitry.
2. Periodically, at a preselected time, a partial mechanical breath assistance is delivered. The mandatory
breaths are synchronized with the patient’s inspiratory effort.
3. Gas provided for spontaneous breathing flows continuously through the ventilator.
4. Ensures that a predetermined number of breaths at a selected VT are delivered each minute.
5. Indicated for patients who are breathing spontaneously, but at a VT and/or rate less than adequate for their
needs. Allows the patient to do some of the work of breathing.
Pressure Support
1. Augments inspiration to a spontaneously breathing patient.
2. Maintains a set positive pressure during spontaneous inspiration.
3. The patient ventilates spontaneously, establishing own rate, VT, and inspiratory time.
4. Pressure support may be used independently as a ventilatory mode or used in conjunction with CPAP or
synchronized intermittent mandatory ventilation.
Positive Pressure Ventilation Techniques
Positive End-Expiratory Pressure
1. Maneuver by which pressure during mechanical ventilation is maintained above atmospheric at end of
exhalation, resulting in an increased functional residual capacity. Airway pressure is therefore positive
throughout the entire ventilatory cycle.
2. Purpose is to increase functional residual capacity (or the amount of air left in the lungs at the end of
expiration). This aids in:
a. Increasing the surface area of gas exchange.
b. Preventing collapse of alveolar units and development of atelectasis.
c. Decreasing intrapulmonary shunt.
d. Improving lung compliance.
e. Improving oxygenation.
f. Recruiting alveolar units that are totally or partially collapsed.
3. Benefits:
a. Because a greater surface area for diffusion is available and shunting is reduced, it is often possible
to use a lower FiO2 than otherwise would be required to obtain adequate arterial oxygen levels. This
reduces the risk of oxygen toxicity in conditions such as acute respiratory distress syndrome
(ARDS).
b. Positive intra-airway pressure may be helpful in reducing the transudation of fluid from the
pulmonary capillaries in situations where capillary pressure is increased (ie, left-sided heart failure).
c. Increased lung compliance resulting in decreased work of breathing.
4. Hazards:
a. Because the intrathoracic pressure is increased by PEEP, venous return is impeded. This may result
in:
i. decreased cardiac output and decreased oxygen delivery to the tissues (especially noted in
hypovolemic patients)
ii. decreased renal perfusion
iii. ICP
iv. iv. hepatic congestion.
b. The decreased venous return may cause antidiuretic hormone formation to be stimulated, resulting in
decreased urine output.
5. Precautions:
a. Monitor frequently for signs and symptoms of respiratory distress—shortness of breath, dyspnea,
tachycardia, chest pain.
b. Monitor frequently for signs and symptoms of pneumothorax (increased PAP, increased size of
hemothorax, uneven chest wall movement, hyper resonant percussion, distant or absent breath
sounds).
c. Monitor for signs of decreased venous return (decreased BP, decreased cardiac output, decreased
urine output, peripheral edema).
d. Abrupt discontinuance of PEEP is not recommended. The patient should not be without PEEP for
longer than 15 seconds. The manual resuscitation bag used for ventilation during suction procedure
or patient transport should be equipped with a PEEP device. In-line suctioning may also be used so
that PEEP can be
e. maintained.
f. Intrapulmonary blood vessel pressure may increase with compression of the vessels by increased
intra airway pressure. Therefore, central venous pressure (CVP), PAP, and pulmonary capillary
wedge pressure may be increased. The clinician must bear this in mind when determining the clinical
significance of these pressures.
Newer Modes of Ventilation
Inverse Ratio Ventilation
1. I:E ratio is greater than 1, in which inspiration is longer than expiration.
2. Potentially used in patients who are in acute severe hypoxemic respiratory failure. Oxygenation is thought
to be improved.
3. Very uncomfortable for patients; need to be heavily sedated.
4. Pressure-controlled inverse ratio ventilation—used in ARDS and acute lung injury.
Airway Pressure Release Ventilation
1. Ventilator cycles between uses a longer inspiratory time.
3. Uses a short expiratory time.
4. Used in severe ARDS/acute lung injury.
Non-invasive Positive Pressure Ventilation
1. Uses a nasal or face mask, or nasal pillows. Delivers air through a volume or pressure-controlled
ventilator.
2. Used primarily in the past for patients with chronic respiratory failure associated with neuromuscular
disease. Now is being used successfully during acute exacerbations. Some patients are able to avoid invasive
intubation. Other indications include acute or chronic respiratory distress, acute pulmonary edema,
pneumonia, COPD exacerbation, weaning, and post-extubation respiratory decompensation.
3. Can be used in the home setting. Equipment is portable and relatively easy to use.
4. Eliminates the need for intubation, preserves normal swallowing, speech, and the cough mechanism.
5. The system has a rate setting as well as inspiratory and expiratory pressure setting.
High-Frequency Ventilation
1. Uses very small VT (dead space ventilation) and high frequency (rates greater than 100/minute).
2. Gas exchange occurs through various mechanisms, not the same as conventional ventilation (convection).
3. Types include:
a. High-frequency oscillatory ventilation.
b. High-frequency jet ventilation.
4. Theory is that there is decreased barotrauma by having small VT and that oxygenation is improved by
constant flow of gases.
5. Successful with infant respiratory distress syndrome, much less successful with adult pulmonary
complications.
Nursing Assessment and Interventions
1. Monitor for complications:
a. Airway aspiration, decreased clearance of secretions, ventilator-acquired pneumonia, tracheal
damage, laryngeal edema
b. Impaired gas exchange
c. Ineffective breathing pattern
d. ET tube kinking, cuff failure, mainstem intubation
e. Sinusitis
f. Pulmonary infection
g. Barotrauma (pneumothorax, tension pneumothorax, subcutaneous emphysema,
pneumomediastinum)
h. Decreased cardiac output
i. Atelectasis
j. Alteration in GI function (stress ulcers, gastric distention, paralytic ileus)
k. Alteration in renal function
l. Alteration in cognitive-perceptual status
2. Suction the patient as indicated.
a. When secretions can be seen or sounds resulting from secretions are heard with or without the use of
a stethoscope
b. After chest physiotherapy
c. After bronchodilator treatments
3. Provide routine care for patient on mechanical ventilator. Provide regular oral care to prevent ventilator-
associated pneumonia. Provide humidity and repositioning to mobilize secretions.
4. Assist with the weaning process, when indicated (patient gradually assumes responsibility for regulating
and performing own ventilations.
a. Patient must have acceptable ABG values, no evidence of acute pulmonary pathology, and must be
hemodynamically stable.
b. Obtain serial ABGs and/or oximetry readings, as indicated.
c. Monitor very closely for change in pulse and BP, anxiety, and increased rate of respirations.
d. The patient is awake and cooperative and displays optimal respiratory drive.
5. Once weaning is successful, extubate and provide alternate means of oxygen.
6. Extubation will be considered when the pulmonary function parameters of VT, VC, and negative
inspiratory pressure are adequate, indicating strong respiratory muscle function.
Community and Home Care Considerations
Patients may require mechanical ventilation at home to replace or assist normal breathing. Ventilator support
in the home is used to keep patient clinically stable and to maintain life.
1. Candidates for home ventilation are those patients who are unable to wean from mechanical ventilation,
and/or have disease progression requiring ventilator support. Candidates for home mechanical ventilator
support:
a. Have a secure artificial airway (tracheostomy tube).
b. Have FiO2 requirement 40%.
c. Are medically stable
d. Are able to maintain adequate ventilation on standard ventilator settings.
2. Patients may choose not to receive home ventilation. Examples of inappropriate candidates for home
ventilation include patients who:
a. Have a FiO2 40%.
b. Use PEEP 10 cm H2O.
c. Require continuous invasive monitoring.
d. Lack a mature tracheostomy.
e. Lack able, willing, appropriate caregivers, and/or caregiver respite.
f. Lack adequate financial resources for care in home.
g. Lack adequate physical facilities:
i. Inadequate heat, electricity, sanitation.
ii. Presence of fire, health, or safety hazards.
3. For patients on mechanical ventilation in the home, a contract and relationship with a home medical
equipment company must be developed to provide:
a. Care of ventilator-dependent patient.
b. Provision and maintenance of equipment.
c. Timely provision of disposable supplies.
d. Ongoing monitoring of patient and equipment.
e. Training of patient, caregivers, and clinical staff on proper management of ventilated patient and use and
troubleshooting of equipment.
4. Equipment required:
a. Appropriate ventilator with alarms (disconnect and high pressure).
b. Power source.
c. Humidification system.
d. Manual resuscitation bag with tracheostomy adapter.
e. Replacement tracheostomy tubes.
f. Supplemental oxygen, as medically indicated.
g. Communication method for patient.
h. Backup charged battery to run ventilator during power failures.
5. Lay caregiver training and return demonstration must include:
a. Proper setup, use, troubleshooting, maintenance, and cleaning and infection control of equipment and
supplies.
b. Appropriate patient assessment and management of abnormalities, including cardiopulmonary
resuscitation, response to emergencies, power and equipment failure.
6. Potential complications include:
a. Patient deterioration, need for emergency services.
b. Equipment failure, malfunction.
c. Psychosocial complications, including depression, anxiety, and/or loss of resources (caregiver, financial,
detrimental change in family structure or coping capacity).
7. Communication is essential with local emergency medical services (fire, police, rescue) and utility
(telephone, electric) companies from whom the patient would need immediate and additional assistance in
event of emergency (eg, power failure, fire).